Pay in 4 interest-free payments of $6.76 Learn more
Ships within 48 hours · Estimated delivery Sep 23 - Sep 28
Use in the nighttime, 2-3 times a week
CU Anschutz Clinical Trial Shows Fewer Heavy Drinking Days PR Newswire AURORA, Colo., July 29, 2026 A study from the University of Colorado Anschutz found that the popular diabetes and weight loss drug reduced heavy drinking and alcohol-related harm in adults with Alcohol Use Disorder AURORA, Colo., July 29, 2026 /PRNewswire/ -- A clinical trial led by researchers at CU Anschutz has found that oral semaglutide, a medication widely used for diabetes and weight loss, reduces heavy drinking in adults with Alcohol Use Disorder (AUD)
However, there are not yet any firm dosing recommendations in therapeutic contexts
Besides, there is growing interest in its application in neurobiology, especially in the treatment of some neurodegenerative disorders like Parkinsons and Alzheimers, because of its capacity to reduce oxidative stress in the neurons
Looking for a glutathione supplement that skips the pills
GLP-1 drugs are often grouped by how long they work in the body
